InBios receives Emergency Use Authorization for its Smart Detect SARS-CoV-2 rRT-PCR Kit for detection of the virus causing COVID-19
InBios International, Inc. announces the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2 SEATTLE (PRWEB) APRIL 08, 2020 InBios International Inc., a leading developer of[…]
Read more